| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.098 | 0.009 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.083 | 0.009 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |